Wed. 1 May 2024, 6:31am ET
Benzinga
Earnings, Earnings Misses, News
G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.20) per share which met the analyst consensus estimate. This is a 62.26 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $14.476 million which missed the analyst consensus estimate of $15.259 million by 5.13 percent. This is a 11.82 percent increase over sales of $12.946 million the same period last year.